EGFR and neoplasm: Comparing with Anti-IL-2 and EGFR inhibitor, a combination of castration with Anti-WNT5A or PLX yields better anti-tumor responses, indicating that blockade of the PC-Treg or PC-TAM interaction may effectively reduce tumor cell growth.